期刊文献+

佩尔地平静脉滴注治疗老年高血压危象的临床研究 被引量:3

CLINIC RESEARCH ON SENIOR HYPERTENSION CRISIS THROUGH VEIN INSTILLATION OF PERDIPINE
下载PDF
导出
摘要 目的观察佩尔地平对老年高血压危象的疗效及安全性。方法老年(≥60岁)高血压危象患者92例,治疗前平均收缩压(236±16)mmHg和/或舒张压(125±11)mmHg,以恒速输液泵持续静滴佩尔地平,剂量为0.5~6μg/(kg·min),根据血压每5min调整一次剂量,每次增加5μg/min直至达到目标血压150~160/100~110mmHg,然后维持此血压水平1~3d。结果用药后5min、10min、30min、1h、2h的平均血压降至231/125,226/123,217/121,207/118,203/107mmHg,24h后达到最大效应,血压平均为(168±11)/(100±9)mmHg,并稳定至用药结束。未发现严重不良反应。结论佩尔地平治疗老年高血压危象起效快,降压作用平稳,安全性高。 Objective observation of the therapeutic effects and securities of Perdipine on senior hypertension crisis. Methods 92 senior(≥60)hypertension sufferers were investigated.The average shrink blood pressure (SBP) and disstole blood pressure (DBP)before treatment were (236±16)mmHg and (125±11)mmHg respectively.Perdipine (Nicardipine) was constantly instilled into sufferer's veins using automatic instillation pump.The adapted doses were 0.5~6μg/(kg·min) and gradually increased every 5 minutes according to the measured blood pressures.Then the measured blood pressure were kept at 150~160/100~110mmHg for 1~3 days. Results After 5min、10min、30min、1h and 2h treatment,the average blood pressure dropped to 231/125mmHg、226/123mmHg、217/121mmHg、207/118mmHg and 203/107mmHg respectively.After 24 hours,the maximum effect was obtained and the average blood pressure was stabilized at (168±11)/(100±9)mmHg until the end of treatment.No obvious side effects were observed. Conclusion Perdipine has significant therapeutic effects for fast and stable blood pressure reduction as well as high securities on senior hypertension crisis.
出处 《中国心血管病研究》 CAS 2004年第8期624-626,共3页 Chinese Journal of Cardiovascular Research
关键词 高血压危象 佩尔地平 老年人 hypertension crisis perdipine senior
  • 相关文献

参考文献8

  • 1[1]郑秋甫.新编内科学[M].北京:人民军医出版社,2002:697
  • 2[3]Joseph Varon,Paul E,Marik.Diagnosis and management of hypertensive crises[ J ].Chest,2000,118( 1 );214-227
  • 3[4]Strauser LM,Groshong T,Tobias JD.Initial experience with isradipine for the treatment of hypertension in children[J].South Med J,2000,93(3):287-293
  • 4[5]Molon E.Pathophysiology and principles of treatment of vasospasm[ J ].J Neuroradiod,1999,26( 1 ):30-35
  • 5[6]Michael J,Groshong T,Tobisa JD.Antihypertensive effects of lercanidipine in experimental hypertensive rate and dogs[ J ].Pediatr-Nephrol,1998,12 ( 1 ):40-42
  • 6[7]Honda T,Hamada M,Shigematsu Y,et al.Effect of antihypertensive therapy on aortic distensibility in patients with essential hypertension:comparison with trichlormethiazide,micardipine and alacepril [ J ].Cardiovase Drugs Ther,1999,13(4):339-346
  • 7[8]Brogden RN,Benfield P.Verapmil; A review of its pharmacologixal properties and therapeutic use in coronary artery disease[ J ].Drugs,1996,51 (5):792-819
  • 8徐泽昌,崔吉君.药物对慢性心衰长期存活率的影响及应用原则[J].心血管病学进展,2001,22(3):147-149. 被引量:11

二级参考文献20

  • 1[1]Packer M,Cohn JN ,Abraham WT,et al. Consensus recommendations for the management of chronic heart failure [J]. Am J Cardiol, 1999,83 (2A): 1A-38A
  • 2[2]The Captopril-Digoxin Multicenter Research Group. Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure[J]. JAMA, 1988,259: 539-544
  • 3[3]The SOLVD Investigators. Effect of enalapril on survival in patents with reduced left ventricular ejection fractions and congestive heart failure [J]. N Engl J Med, 1991,325: 293-302
  • 4[4]Cohn JN,Johnson G,Ziesche S,et al. A comparison of enalapril with bydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure[J]. N Engl J Med, 1991,325: 303-310
  • 5[5]The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)[J]. N Engl J Med, 1987, 316:1429-1435
  • 6[6]Waagstein F,Bristow MR,Swedberg K,et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy[J]. Lancet, 1993,342:1441 - 1446
  • 7[7]Tsuyuki RT,Yusuf S,Rouleau JL,et al. Combination neurohormonal blockade with ACE inhibitors,angiotensin Ⅱ antagonists and beta-blockers in patients with congestive heart failure:design of the Randomized Evaluation of Strategies for left Ventricular Dysfunction (RESOLVD) Pilot Study[J]. Can J Cardiol, 1997,13:1166-1174
  • 8[8]The International Steering Committee. Rationale,desing,and organization of the Metoprolol CR/XL Randomized Intervention Trial in Heart Failure (MERIT-HF) [J]. Am J Cardiol, 1997,80(suppl 9B): 54J-58J
  • 9[9]CIBIS Ⅱ Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study (CIBIS- Ⅱ ): a randomized trial[J]. Lancet, 1999 , 353: 9-13
  • 10[10]Packer M,Colucci WS,Sackner-Bernstein JD,et al. Double-blind,placebocontrolled study of the effects of carvedilol in patients with moderate to severe heart failure[J]. Circulation, 1996 , 94: 2793-2799

共引文献10

同被引文献15

  • 1熊丽,章军建.颈动脉狭窄的介入治疗研究进展[J].卒中与神经疾病,2004,11(6):397-398. 被引量:8
  • 2唐军,陈颉,刘作勤.神经介入治疗的并发症的探讨[J].医学影像学杂志,2005,15(3):184-187. 被引量:4
  • 3彭波.联合用药治疗妊高症136例临床疗效观察[J].地方病通报,2006,21(6):113-113. 被引量:9
  • 4[1]Hayashi Y,Ohtani M,Sawa Y,et al.Synthetic human alpha-atrial natriuretic peptide improves the management of postoperative hypertension and renal dysfunction after the repair of abdominal aortic aneurysm.J Cardiovasc Pharmacol,2003,42(5):636-641.
  • 5[2]Krishnaiah S,Satyanarayana V,Bhaskar P.Influence of menthol and pressure-sensitive adhesives on the in vivo performance of membranemoderated transdermal therapeutic system of nicardipine hydrochloride in human volunteers.Eur J Pharm Biopharm,2003,55 (3):329-337.
  • 6[3]Mugo M,Govindarajan G,Kurukulasuriya,et al.Hypertension in pregnancy.Curr Hypertens Rep,2005,7 (5):348-354.
  • 7[7]Song J,Zhang S,Qiao Y,et al.Predicting pregnancy-induced hypertension with dynamic hemodynamics.Eur-J Obstet Gynecol Reprod Biol,2004,117 (2):162-168.
  • 8[9]Krishnaiah S,Satyanarayana V,Bhaskar P,et al.Formulation and in vivo evaluation of membrane-moderated transdermal therapeutic systems of nicardipine hydrochloride using carvone as a penetration enhancer.Drug Deliv,2003,10(2):101-109.
  • 9Krishnaiah S, Satyanarayana V, Bhaskar P, et al. Formulation and in vivo evaluation of membrane - moderated transdermal therapeutic systems of nicardipine hydrochloride using earvone as a penetration enhancer[J].Drug Deliv, 2003, 10 (2): 101.
  • 10孙丽洲.实用临床诊疗规范——妇产科:妊娠高血压综合征[J].中国实用乡村医生杂志,2007,14(10):15-16. 被引量:3

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部